In a remarkable medical advancement, Chinese researchers have successfully reversed Type 1 diabetes in a female patient using her stem cells. This significant development could potentially ...

SHANGHAI (Reuters) -China's Innovent Biologics said on Monday its GLP-1 injection led to more weight loss and better control of blood sugar in patients with diabetes than injectable semaglutide, the ...

An illustration of a pluripotent stem cell, which can be coaxed to develop into various kinds of tissue MedicalRF.com via Getty Images Last year, cell biologist Deng Hongkui and his team at Peking ...

Sanofi (NASDAQ:SNY) said on Wednesday that Tzield was approved in China as the first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes. Approval is based on the ...

Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes Approval based on the TN-10 study, demonstrating Tzield’s ability to delay the ...

Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of a button Zeng Jianjun has dropped 10 pounds in the two months since New ...

A new study led by researchers from Peking University, published in Health Data Science, reveals a sharp rise in the burden of early-onset type 2 diabetes (T2D) among adolescents and young adults in ...